Statera Biopharma, Inc. STAB

Full chart Compare
Set alert

Price alert · STAB

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:00 PM EST

0.0001 Day range 0.0001
0.0001 52-week range 0.0266
YTD
-33.33%
1 year
+100.00%

Revenue & Expenses

Revenue → Gross Profit: $998.72KGross Profit → Expenses: $998.72KRevenue → Cost of Revenue: $488.31KExpenses → Selling, General & Admin: $19.91MExpenses → Research & Development: $11.83MExpenses → Other Operating Expenses: $67.60MExpenses → Other Expenses: $3.51MNet Loss → Expenses: $101.85MGross Profit$998.72KNet Loss$101.85MCost of Revenue$488.31KExpenses$102.85MSelling, General & Admin$19.91MResearch & Development$11.83MOther Operating Expenses$67.60MOther Expenses$3.51MRevenue$1.49M

Latest period ending Dec 31, 2021 · select a line to chart its full history

STAB annual income statement
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
1.49M01.11M1.14M1.95M
998.72K01.11M1.14M1.95M
-98.34M-10.50M-2.36M-4.80M-5.60M
-101.85M-12.09M-2.65M-3.61M-9.71M
-2.90-1.66-0.23-0.32-0.87
STAB annual balance sheet
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
1.84M593.87K1.13M3.62M4.23M
21.17M1.04M2.04M4.53M9.63M
22.68M4.69M1.05M920.38K2.22M
16.26M2.00M000
-1.57M-3.66M-4.06M-1.45M2.20M
STAB annual cash flow
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
-28.19M-5.08M-2.66M-4.61M-6.61M
13.46M-9.64K156.78K3.97M3.89M
20.99M5.68M055.22K0
-182.97K-9.64K48.65K8.27K4.55K
6.25M592.22K-2.49M-613.31K-2.67M